Apex Treasury Appoints Seasoned Financier Stephen CuUnjieng to Board, Bolstering De-SPAC Expertise
summarizeSummary
Apex Treasury Corporation announced a change to its board of directors, with the resignation of David Mikulecky and the appointment of Stephen CuUnjieng, a highly experienced financier, to the board and key committees.
check_boxKey Events
-
Director Resignation
David Mikulecky resigned from the board of directors, effective March 9, 2026. No disagreements with the company were reported.
-
New Independent Director Appointed
On March 13, 2026, Stephen CuUnjieng was appointed as a Class I independent director to the Board, also joining the Audit and Compensation Committees.
-
Strategic Expertise for SPAC
Mr. CuUnjieng brings extensive experience as a senior financier with deep relationships in Asia, including roles with a sovereign wealth fund and as Chairman and CEO of Evercore Asia, which is highly beneficial for Apex Treasury Corporation's mission as a SPAC to identify and complete a business combination.
-
Director Compensation
In connection with his appointment, Mr. CuUnjieng will receive 30,000 Class B ordinary shares from the Sponsor, valued at approximately $299,400 based on the current stock price.
auto_awesomeAnalysis
Apex Treasury Corporation, a SPAC, has appointed Stephen CuUnjieng, a highly experienced financier with deep relationships in Asia and a background in sovereign wealth funds and investment banking, to its board of directors. This appointment is significant as Mr. CuUnjieng's expertise is directly relevant to identifying and executing a successful business combination, which is the primary objective of a SPAC. His addition to the Audit and Compensation Committees further strengthens governance. While a director also resigned, the appointment of a director with such a strategic profile is a positive development for the company's future prospects.
At the time of this filing, APXT was trading at $9.98 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $458.7M. The 52-week trading range was $9.87 to $10.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.